Semaglutide
A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT.
999 PubMed studies analyzed
Loading evidence profile...
This evidence profile for Semaglutide is generated deterministically from 999 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.